| Literature DB >> 34983849 |
Helgi I Ingólfsson1, Chris Neale2, Timothy S Carpenter1, Rebika Shrestha3, Cesar A López2, Timothy H Tran3, Tomas Oppelstrup1, Harsh Bhatia4, Liam G Stanton5, Xiaohua Zhang1, Shiv Sundram1, Francesco Di Natale4, Animesh Agarwal2, Gautham Dharuman1, Sara I L Kokkila Schumacher6, Thomas Turbyville3, Gulcin Gulten3, Que N Van3, Debanjan Goswami3, Frantz Jean-Francois3, Constance Agamasu3, Jeevapani J Hettige2, Timothy Travers2, Sumantra Sarkar7, Michael P Surh1, Yue Yang1, Adam Moody4, Shusen Liu4, Brian C Van Essen4, Arthur F Voter8, Arvind Ramanathan9, Nicolas W Hengartner2, Dhirendra K Simanshu3, Andrew G Stephen3, Peer-Timo Bremer4, S Gnanakaran2, James N Glosli1, Felice C Lightstone1, Frank McCormick10,11, Dwight V Nissley10, Frederick H Streitz12.
Abstract
RAS is a signaling protein associated with the cell membrane that is mutated in up to 30% of human cancers. RAS signaling has been proposed to be regulated by dynamic heterogeneity of the cell membrane. Investigating such a mechanism requires near-atomistic detail at macroscopic temporal and spatial scales, which is not possible with conventional computational or experimental techniques. We demonstrate here a multiscale simulation infrastructure that uses machine learning to create a scale-bridging ensemble of over 100,000 simulations of active wild-type KRAS on a complex, asymmetric membrane. Initialized and validated with experimental data (including a new structure of active wild-type KRAS), these simulations represent a substantial advance in the ability to characterize RAS-membrane biology. We report distinctive patterns of local lipid composition that correlate with interfacially promiscuous RAS multimerization. These lipid fingerprints are coupled to RAS dynamics, predicted to influence effector binding, and therefore may be a mechanism for regulating cell signaling cascades.Entities:
Keywords: RAS dynamics; RAS-membrane biology; massive parallel simulations; multiscale infrastructure; multiscale modeling
Mesh:
Substances:
Year: 2022 PMID: 34983849 PMCID: PMC8740753 DOI: 10.1073/pnas.2113297119
Source DB: PubMed Journal: Proc Natl Acad Sci U S A ISSN: 0027-8424 Impact factor: 11.205
Fig. 1.Experimental input and computational approach. (A) Diffusion mapping of single molecules of KRAS4b tethered to or within 100 nm of the PM in a 16 × 16-μm2 region of a live HeLa cell accumulated over 10 s. (B) Crystal structures of wild-type KRAS in active (green and blue; GppNHp-bound) and inactive (gray; GppCH2p-bound configurations). (C) Average macro model lipid composition. (D–F) The Multiscale Machine-learned Modeling Infrastructure (MuMMI). (D) Representative snapshots of each of the different lipid distributions in the inner leaflet of a 0.3 × 0.3-μm2 region of the full 1 × 1-μm2 macro simulation; color saturation indicates local lipid density. (E) Schematic illustrating latent space encoding of lipid composition in 30 × 30-nm2 membrane patches. From the candidate patches (blue and green), those that are most dissimilar (green) to existing (white) CG simulations are selected and used to spawn new CG simulations. (F) Representative CG simulation systems (water not shown). (G) Improvement of macro model parameter inputs from feedback iteration. (H) Distribution of CG simulation duration and (Inset) number of RAS per patch.
Fig. 2.Lipid-dependence of RAS colocalization. (A) Representative macro model inner leaflet lipid densities around RAS, shown separately (small boxes) and together (large central box). Color saturation indicates local lipid density. (B) Population ratio of RAS multimer sizes observed in the macro simulation vs. a random uniform distribution. (C) Average number of RAS in macro model regions (radius 5 nm) along the primary embedding dimension (PED) from function preserving projection analysis (). Vertical lines denote thresholds used to define high-RAS (HRC), initial average (ARC), and low-RAS (LRC) lipid compositions. (D) Distributions of inner leaflet lipid concentrations for all patches with RAS (black), HRC (red), and LRC (blue). The ARC is represented by a dashed vertical line. (E) Surface plasmon resonance sensorgrams of RAS adhesion to liposomes with the LRC, ARC, and HRC lipid compositions. Each subplot contains multiple traces representing distinct RAS concentrations (twofold dilutions, 60 to 0.1 μM).
Fig. 3.Diffusion of RAS and lipids. (A and B) Distributions of lateral diffusion rates, D, for lipids and RAS in (A) CG simulations and (B) FLCS on the ARC. (C) Values of D for PIP2 conditioned on interaction with monomeric RAS in the CG simulations. (D) Proportion of each lipid type in RAS’s first solvation shell (within 0.55 nm), normalized by its molar fraction in the initial average lipid mixture (ARC), as a function of RAS aggregate size. (E) Values of D as a function of RAS aggregate size. (F) Mean square displacement (MSD) curves of JF646-labeled RAS from SPT on supported lipid bilayers with the low (LRC), average (ARC), and high (HRC) RAS lipid compositions.
Fig. 4.RAS–RAS interactions. (A) Distributions of radii of gyration based on RAS aggregation number. (B) Sampling of the protein–protein interfaces projected as a density map of two angles. The first angle (1stRASΘ, in red) is between the vectors center of mass (COM) of the first RAS G-domain to COM of the second RAS G-domain (1stRAS GCOM→2ndRAS GCOM) and 1stRAS GCOM→1stRAS T35. The second angle (2ndRASΘ, in blue) is between the vectors 1stRAS GCOM→2ndRAS GCOM and 2ndRAS GCOM→2ndRAS T35. Illustrative examples of the interfaces defined by the angles are shown. White dashed regions indicate various interfaces presented in the literature (13, 31, 32, 66). Data are only plotted for 1stRAS GCOM→2ndRAS GCOM < 6.0 nm from simulations where the RAS proteins start apart (). (C) PIP2 remodeling based on RAS–RAS G-domain separation, dG-G, shown with G-domain centers of mass on the x axis. Data show PIP2 density (red heatmaps), PIP2 density integrated over −4 nm < y < 4 nm (black lines), and a model reflecting translation of static PIP2 density distributions (blue dashed lines). Differences between the integrated density and the static translation model indicates regions of enrichment and depletion of PIP2 lipids during RAS–RAS association. (D) Preferential binding coefficients showing the enrichment of PIP2 among lipids in contact with RAS, dPIP2, as a function of the number of PIP2 per CG patch, shown separately for RAS dimers and monomers. The larger dPIP2 values for dimers indicate that dimers formation is favored by higher PIP2 concentration.
Fig. 5.RAS orientations. (A) Definition of tilt and rotation angles based on a reference orientation with the long axis of G-domain helix 5 perpendicular to the membrane surface. (B) Kinetic states of G-domain orientation. Dots represent Markov state modeling (MSM) microstates and color associates sampled orientations with the nearest microstate. Blue isocontours define the likelihood of membrane-based occlusion of RAF binding. (C) G-domain disposition in simulations with one RAS. (D–G) Representative configurations of α, β, and β′ states illustrating orientation-dependent competence for effector binding. (H) MSM state populations and transition rates. (I) State-specific distributions of the displacement of the H166 backbone bead from the bilayer center, dzH166. (J) G-domain tilt vs. dzH166.
Fig. 6.RAS–lipid interactions. (A) Relative lipid densities around monomeric RAS. The center of mass of the G-domain is at the origin and the backbone bead of C-terminal HVR residue C185 is on the positive x axis. (B) The confusion matrix shows the accuracy of ML predictions of the RAS state based on local lipid compositions. Each row corresponds to an actual state (computed using tilt/rotation) and each column to a predicted state; off-diagonal elements are the errors made by the prediction. (C) Local lipid composition is predictive for transitions between states. Transition probabilities increase when noted lipid concentrations (+) increase and (−) decrease (see ). (D) RAF-occlusion vs. PIP2 content.